Clinical research
Amberen's flagship menopause and perimenopause supplements have gone through years of sophisticated and rigorous testing. Below are details about the significant clinical results for these two formulas.
Clinical Trial: Amberen Menopause Relief (2016)
12-week, randomized, placebo-controlled, double-blind study with 125 women aged 42–60 with mild to moderate menopause symptoms.
Results
Amberen was shown to be a safe and well-tolerated supplement with no adverse side effects.‡ Compared to the placebo group, women who took Amberen reported significant improvements in many menopause symptoms∞:
had reduced anxiety & stress∞
had fewer hot flashes∞
had better sleep∞
had reduced irritability∞
had better concentration∞
had reduced mood swings∞
had less night sweats∞
had more energy∞
had less muscle & joint pain∞
had increased sex drive∞
had fewer headaches∞
had less excitability∞
Clinical Trial: Amberen Perimenopause Relief (2020)
180-day, randomized, placebo-controlled, double-blind study with 105 women aged 36–50 with mild to moderate perimenopause symptoms.
Results
Amberen Perimenopause was shown to be a safe and well-tolerated supplement with no adverse side effects.‡ Compared to the placebo group, women who took Amberen reported significant improvements in many perimenopause symptoms,∞ including menstrual regularity^:
had reduced anxiety & stress∞
had fewer hot flashes∞
had less night sweats∞
had more energy∞
had reduced mood swings∞
had better sleep∞
had more regular periods∞
had increased sex drive∞
had reduced irritability∞
had fewer headaches∞
